as 11-21-2024 4:00pm EST
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | SAN CLEMENTE |
Market Cap: | N/A | IPO Year: | 1992 |
Target Price: | $173.00 | AVG Volume (30 days): | 241.1K |
Analyst Decision: | Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.57 | EPS Growth: | N/A |
52 Week Low/High: | $83.26 - $196.26 | Next Earning Date: | 11-12-2024 |
Revenue: | $2,340,097,000 | Revenue Growth: | 4.04% |
Revenue Growth (this year): | 4.42% | Revenue Growth (next year): | 4.03% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Jain Vivek | ICUI | Chairman and CEO | Nov 1 '24 | Sell | $172.25 | 12,000 | $2,062,136.38 | 104,593 | |
Jain Vivek | ICUI | Chairman and CEO | Oct 1 '24 | Sell | $178.91 | 12,000 | $2,141,579.92 | 104,593 | |
Jain Vivek | ICUI | Chairman and CEO | Sep 3 '24 | Sell | $163.45 | 12,000 | $1,961,540.40 | 104,593 | |
Woolson Daniel | ICUI | VP, GM-Infusion Capital | Aug 30 '24 | Sell | $163.22 | 2,502 | $408,370.19 | 13,107 |
ICUI Breaking Stock News: Dive into ICUI Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
Simply Wall St.
8 days ago
GuruFocus.com
9 days ago
Morningstar Research
9 days ago
Argus Research
9 days ago
Zacks
9 days ago
MT Newswires
9 days ago
Associated Press Finance
9 days ago
The information presented on this page, "ICUI ICU Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.